Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Primary-Mode-Of-Action Rule For Combo Products Is Similar To Earlier Draft

This article was originally published in The Gray Sheet

Executive Summary

FDA's "primary-mode-of-action" 1final rule for combination products largely mirrors the language of last year's proposed version, although the agency adds clarification on various issues raised by stakeholders
Advertisement

Related Content

US Combo Product Designation Appeal Process Limited In Proposed Rule
US Combo Product Designation Appeal Process Refined In Proposed Rule
Be Careful What You Ask For With Combo Product Designation Requests
Be Careful What You Ask For With Combo Product Designation Requests
Plan Carefully In Writing Combo Product Designation Requests, Experts Say
Industry Looks To FDA’s New Combo Products Chief For Answers
Combo Product Coalition Drafting Proposal On Regulatory Selection Criteria
Combo Product Guidances On The March; Primary Mode Of Action Clarified
Combo Product Dispute Resolution, Primary Mode Of Action Detailed By OCP
Combo Product Dispute Resolution, Primary Mode Of Action Detailed By OCP
Advertisement
UsernamePublicRestriction

Register

MT022586

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel